Drug Information

Drug General Information
Drug ID
D0KX6E
Former ID
DNCL003480
Drug Name
DI-Leu16-IL2
Indication B-cell lymphoma [ICD9: 202.8; ICD10:C85.1] Phase 1/2 [524320]
Company
Alopexx Oncology
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Modulator [550428]
KEGG Pathway Hematopoietic cell lineage
References
Ref 524320ClinicalTrials.gov (NCT01874288) Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHL. U.S. National Institutes of Health.
Ref 550428National Cancer Institute Drug Dictionary (drug id 599668).